JP Morgan Chase
CHTP

JP Morgan Chase’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

JP Morgan Chase’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-17,240
Closed -$52K – 4437
2013
Q3 		$52K Sell
17,240
-43,147
-71% -$124K ﹤0.01% 4256
2013
Q2 		$139K Buy
+60,387
New +$122K ﹤0.01% 4076

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase's CHTP Position: Q4 2013 in Review

JP Morgan Chase sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q4 2013, closing a stake of 17,240 shares — an estimated $52K sold.

JP Morgan Chase first reported a position in CHTP in Q2 2013 and held it in 2 quarters. The position peaked at $139K in Q2 2013. 78 funds tracked by Wall St. Rank hold CHTP as of Q4 2013.

  • JP Morgan Chase reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 17,240 CHELSEA THERAPEUTICS INT'L LTD shares in Q4 2013, an estimated $52K.
  • JP Morgan Chase first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's CHELSEA THERAPEUTICS INT'L LTD position peaked at $139K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.